Peregrine Capital Management’s Esperion Therapeutics ESPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-169,239
| Closed | -$6.63M | – | 315 |
|
|
2018
Q2 | $6.63M | Sell |
169,239
-10,224
| -6% | -$401K | 0.17% | 191 |
|
|
2018
Q1 | $13M | Sell |
179,463
-76,629
| -30% | -$5.54M | 0.32% | 127 |
|
|
2017
Q4 | $16.9M | Sell |
256,092
-33,935
| -12% | -$2.23M | 0.4% | 104 |
|
|
2017
Q3 | $14.5M | Sell |
290,027
-28,640
| -9% | -$1.44M | 0.35% | 117 |
|
|
2017
Q2 | $14.7M | Buy |
+318,667
| New | +$14.7M | 0.37% | 103 |
|